Senior Lecturer and Consultant in Clinical Oncology
Centre for Cancer Research and Cell Biology, Queen’s University of Belfast.
Dr Gerry Hanna is a Clinical Senior Lecturer in Radiation Oncology at the Centre for Cancer Research and Cell Biology, Queen’s University of Belfast. Dr Hanna’s research interests are the use of PET/CT in radiotherapy planning for lung cancer, overcoming radiotherapy resistance, stereotactic ablative radiotherapy and systemic therapy and immunotherapy combinations with radiotherapy. He is chief investigator of the IAEA “PERTAIN” study and co-chief Investigator of the CONCORDE study, a proposed UK study of novel agents with radiotherapy in the treatment of lung cancer. Away from work he enjoys cycling, good music and pretending to play the piano.